Therapeutic compounds

Details Therapeutic compounds Therapeutic compounds

2007-11-06

2007-11-06

Andres, Janet L. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C544S364000, C540S580000, C540S607000

Reexamination Certificate

active

10375687

ABSTRACT:
The present invention provides compounds, for example, of formula (I):wherein R1, R2, and R3have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods, and processes and intermediates useful for preparing compounds of formula I.

REFERENCES:
patent: WO 97/46899 (1997-12-01), None
patent: WO 97/48700 (1997-12-01), None
Bromidge, MS et al ‘1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonis with potential as antidepressant/Anxiolytic agents’ CA 133:275848 (2000).
Bromidge etal CA 133:275848.
1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and Selective 5-HT2cReceptor Inverse Agonists with Potential as Antidepressant/Anxiolytic Agents, by S.M. Bromidge, et al, Bioorganic & Medicinal Chemistry Letters 10 (2000) 1863-1866.

Affiliated with

Also associated with

Rating

Therapeutic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3839016